SciELO - Scientific Electronic Library Online

 
vol.37 issue2Variability in the thrombophilia evaluation criteria by medical specialists in adult patients with arterial thrombosis: Colombia, september 2021 to January 2022Amyand's hernia with perforated appendix and intestinal necrosis: a case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Medicas UIS

Print version ISSN 0121-0319On-line version ISSN 1794-5240

Medicas UIS vol.37 no.2 Bucaramanga May/Aug. 2024  Epub May 10, 2024

https://doi.org/10.18273/revmed.v37n2-2024007 

Artículos originales

HIV Pre-exposure Prophylaxis Awareness, Eligibility and Intention in Men Who Have Sex with Men and Transgender Women: a cross-sectional study in Colombia 2020 - 2021

Conciencia, elegibilidad e intención respecto a la Profilaxis Pre-exposición al VIH en hombres que tienen sexo con hombres y mujeres transgénero: estudio transversal en Colombia, 2020-2021

Héctor Fabio Mueses-Marín¹ 
http://orcid.org/0000-0002-0608-6656

Beatriz Eugenia Alvarado-Llano² 
http://orcid.org/0000-0002-1269-405X

María Camila Bolívar-Rocha1  ³ 
http://orcid.org/0000-0003-4637-4131

Ximena Galindo-Orrego 
http://orcid.org/0000-0003-0422-9200

Julián Andrés Torres-Isasiga 
http://orcid.org/0000-0001-6477-9867

Jorge Luis Martínez-Cajas 
http://orcid.org/0000-0003-2847-7823

1 Estadístico. Magister en Epidemiología. Corporación de Lucha Contra el SIDA. Cali, Colombia. Correo electrónico: centroinvestigaciones@cls.org.co.

2 Médica. Magister en Epidemiología. Doctora en Salud Pública. Public Health Science, Queens University, Kingston ON, Canada.

3 Socióloga. Magister en Salud Pública. Departamento de Salud Pública y Epidemiología, Pontificia Universidad Javeriana, Cali, Colombia.

4 Médica. Magister en Ciencias Biomédicas. Corporación de Lucha Contra el SIDA. Cali, Colombia.

5 Médico. Especialista en Medicina interna. Especialista en infectología. Moses Division, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx NY, USA.

6 Médico. Especialista en Medicina interna. Especialista en infectología. Division of infectious Diseases, Department of Medicine, Queens University. Kingston ON, Canada. nse to any of those items.


Abstract

Background:

Despite overwhelming evidence supporting the efficacy and effectiveness of Pre-Exposure Prophylaxis (PrEP) in HIV prevention, its adoption has been marginal. In Colombia, more information about eligibility, awareness, and intentions to use PrEP in target populations and how these relate to social determinants is needed.

Aim:

To assess PrEP awareness, the motivational cascade, and the social conditions related to the cascade.

Methods:

A cross-sectional study in a non-probabilistic sample was conducted between April 2020 and February 2021 among 552 Men with Sex with Men (MSM) and 158 Transgender Women (TGW). We used the Poisson regression to explore the associations between PrEP eligibility, awareness, and elements of the motivational PrEP cascade (willingness, intention, and self-perceived need to take) and their sociodemographic characteristics.

Results:

51.2 % of the participants were aware of PrEP, 58.7 % were willing to use it, 45 % were self-perceived as PrEP candidates, and 56.2 % intended to take it.TGW were less likely to be aware but more willing to use PrEP than the sample of MSM interviewed face-to-face. Low education was related to low PrEP awareness and low income to low willingness to start PrEP.

Conclusions:

These results support the pertinence of the cascade concept to describe the stage of the target population regarding eligibility and motivation to take it. To accelerate PrEP implementation, efforts are needed to increase awareness among MSM and TGW with focalized strategies for those with low socioeconomic status.

Keywords: HIV; Men Who Have Sex with Men; Transgender women; Pre-exposure Prophylaxis; Motivational PrEP cascade

Resumen

Introducción:

A pesar de la enorme evidencia que apoya la eficacia y efectividad de la Profilaxis Pre-exposición (PrEP) para el VIH, su adopción continúa siendo marginal. En Colombia, poco se sabe sobre los determinantes sociales y su efecto en la elegibilidad, familiaridad e intención de uso de la PrEP en poblaciones de interés.

Objetivo:

Evaluar la familiaridad con la PrEP, la cascada motivacional de la PrEP y las condiciones sociales como determinantes de esta cascada.

Métodos:

Entre abril 2020 y febrero 2021 se realizó un estudio transversal en una muestra no probabilística de 552 Hombres que tienen Sexo con Hombres (HSH) y 158 Mujeres Transgénero (MTG). Usando la regresión de Poisson, se exploraron las asociaciones entre elegibilidad, familiaridad y elementos de la cascada motivacional de PrEP (voluntad, intención y necesidad autopercibida de tomarla) con las características sociodemográficas.

Resultados:

El 51,2 % sabían de la PrEP, el 58,7 % estaban dispuestos a utilizarla, el 45 % se percibían como candidatos a PrEP, y 56,2 % tenían intención de tomarla. Una baja escolaridad se relacionó con una baja familiaridad con la PrEP y los bajos ingresos con menor intención de uso. Las MTG estaban menos enteradas sobre la PrEP, pero estaban más dispuestas a usarla que los HSH que fueron entrevistados en persona.

Conclusión:

Los resultados apoyan la pertinencia del concepto de la cascada de PrEP para describir el estado de elegibilidad y motivación para tomarla. Para acelerar la implementación de la PrEP, se debe incrementar su conocimiento entre HSH y MTG con estrategias focalizadas en poblaciones menos escolarizadas.

Palabras claves: VIH; Hombres que tienen sexo con Hombres; Personas Transgénero; mujeres Transgénero; Profilaxis Pre-Exposición; Cascada motivacional de la PrEP

Introduction

By 2021, in Colombia, 170 000 People were Living With HIV (PLWH), of whom 8600 were new cases, and 7600 (88 %) were men1. Current HIV incidence trends are difficult to estimate because the COVID-19 pandemic interfered with HIV testing and delivery of treatment and prevention interventions worldwide2. In Colombia, the HIV epidemic is concentrated in Men who have Sex with Men (MSM) and Transgender Women (TGW), with a high prevalence of 17 % and 21.4 %, respectively3,4. The increased annual age-adjusted HIV incidence in Colombia between 2008 (12.35 per 100 000 habitants) and 2016 (23,1 per 100 000 habitants)5 is concerning and justifies a renewed effort to cut down on new HIV infections.

In 2020, the World Health Organization (WHO) and the United Nations Program on HIV/AIDS UNAIDS proposed intensified HIV goals, namely 95 % HIV detection, 95 % treatment initiation, and 95 % treatment engagement plus the adoption of combined prevention interventions, including HIV Pre-Exposure Prophylaxis (PrEP), in the global strategy to eliminate HIV by 20306. PrEP involves the administration of antiretroviral medications to HIV-negative individuals to prevent the acquisition of HIV. PrEP can reduce the risk of HIV acquisition by more than 90 % while offering an excellent safety profile, as demonstrated in multiple clinical trials7,8. The combination of Tenofovir Disoproxil Fumarate and emtricitabine (TDF/FTC) has been used as a preferred backbone of HIV infection treatment for two decades. Additionally, TDF/FTC has demonstrated efficacy/effectiveness and safety in multiple clinical and demonstration PrEP trials and has become the mainstay of HIV PrEP worldwide8-10. HIV PrEP has also resulted in unprecedented reductions in HIV incidence in population studies around the world11,12. Consequently, many countries have adopted PrEP as part of a set of interventions to stop the HIV epidemic13. Furthermore, PrEP has demonstrated effectiveness at reducing new HIV infections in a variety of settings14, including some where high HIV detection and treatment had not previously resulted in a reduction of HIV incidence12. This evidence strongly suggests that HIV PrEP is necessary to meet the targets required for Ending the HIV Epidemic (EHE).

Despite the demonstrated effectiveness of PrEP, uptake has been slow. Latin America (LA), Peru, Mexico, and Colombia have conducted demonstration projects, but PrEP still needs to be utilized more needs to be widely utilized15. For instance, in Brazil16, at the forefront of PrEP implementation in LA, PrEP uptake across the country ranges from 0.6 % to 24 %. Notably, in Colombia, PrEP was provided for free to participants in a demonstration project, but its provision was halted at the end of the project (study participant verbal communication). In contrast, Brazil and Chile made tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) available for PrEP under their public health system in 2017 and 2019, respectively16-18. TDF/FTC was approved for PrEP in Colombia by the regulatory agency INVIMA in early 2019. However, this approval was not widely advertised, and the medication was not initially publicly funded for PrEP. The Colombian government incorporated TDF/FTC in the publicly funded formulary at the end 202119. In the same year, the Colombian HIV national clinical guidelines endorsed PrEP20. Recently, in July 2023, national clinical and implementation guidelines were issued for PrEP, which included recommendations for TDF/FTC, Tenofovir Alafenamide/emtricitabine (TAF/FTC), dapivirine vaginal ring, oral maraviroc and parenteral cabotegravir for key populations21. At the current stage, evidence is required on the need and willingness of key populations to inform further PrEP implementation. Previous studies in Colombia have shown that social (HIV stigma, poverty), personal (lack of knowledge, lack of prescription skills), and health services barriers (funding for PrEP) may limit further adoption of PrEP22-24.

In the adoption process of PrEP, it is essential to estimate the size of the eligible population and their awareness of and willingness to use it. Likewise, the factors that determine these parameters must be well understood. Nevertheless, more evidence must be generated in the Colombian setting. Therefore, we decided to use the elements of the motivational PrEP cascade, as proposed by Parsons et al25, to track the progression of PrEP adoption in a sample of two key population groups, namely Men who have Sex with other Men and Trans Gender Women MSM and TGW. The study objectives were: 1) to estimate the proportion of individuals who are PrEP eligible, the proportion willing to take PrEP, the proportion of those who self-perceived as PrEP eligible, and the proportion who had any previous PrEP experience; and 2) to examine the social conditions related to each outcome of the motivational PrEP cascade.

Methods

Study design: This cross-sectional study conducted in Colombia aimed to collect data on PrEP-related adoption outcomes in MSM and TGW and their determinants. We recruited a non-probabilistic sample of MSM and TGW between April 2020 and February 2021.

Sampling and recruitment. Online recruitment, which was necessary during the early COVID-19 pandemic, was initiated in April 2020 and ended in December 2020. The study was advertised on social media such as Facebook, Twitter, and Grindr. For face-to-face recruitment, the assistance of leaders of MSM and TGW organizations who approached potential participants in person was required. A face-to-face survey was conducted between October 2020 and February 2021 in Medellin, Bogota, and Cali, the three major Colombian cities. There were six interviewers, all with experience working with the LGTBQ community. The interviewers visited the TGW social venues, where they obtained consent and conducted interviews. These venues included community organizations, sex work streets, parks, or neighborhoods often visited by transgender people TGW. In the case of MSM, the interviewers visited community organizations, social venues, and LGTBQ events or recruited participants from individuals referred by friends and LGTBQ networks.

Study population: In the online questionnaire, individuals who self-identified as MSM or TGW and self-reported an HIV-negative status in the screening questions were prompted to complete the survey. For the face-to-face survey, individuals were recruited if they self-identified as MSM or a TGW, reported to be HIV-negative, and older than 18 years old. Further in the analysis stage, participants who self-reported to be living with HIV and those who reported residing outside of Colombia were excluded.

Assessments and measures: the questionnaire developed was based on published questionnaires previously used for PrEP research26-27and validated exclusively in a sample of MSM in Colombia22. The questionnaire includes sociodemographic characteristics, PrEP perceptions, knowledge, self-efficacy, HIV related behaviors, among others. The survey had 167 questions and could be completed in approximately 30 minutes. For this report, we used sociodemographic data such as age, education, employment, living arrangements, socioeconomic status (defined as the socioeconomic strata of the neighborhood), and health insurance status. Before asking any question specific to PrEP, participants were provided with a statement on PrEP in Spanish: The English translation reads, "Pre-exposure prophylaxis (PrEP) is an HIV infection prevention strategy where HIV-negative individuals take anti-HIV medications before coming into contact with HIV to reduce their risk of becoming infected. These medications can prevent HIV from establishing an infection within the body. PrEP has been shown to reduce the risk of HIV infection through sexual contact in gay and bisexual men, transgender women, and heterosexual men and women, as well as in people who inject drugs. It does not protect against other sexually transmitted infections (STIs), nor does it prevent pregnancy. It is not a cure for HIV. Using tenofovir/emtricitabine-TDF/ FTC as PrEP provides a 96 % to 99 % reduction in the risk of infection in HIV-negative people who take the pills every day as directed. If you miss a daily dose, the level of protection against HIV may decrease. It only works if you take the medicine. People who use PrEP correctly and consistently have higher levels of protection against HIV."

Six PrEP outcomes were assessed using the Motivational PrEP cascade as a framework25. The PrEP cascade describes the stages of engagement with PrEP as an HIV prevention strategy. The stages of the PrEP cascade vary by studies but generally move from an awareness of PrEP for HIV prevention to deciding to use PrEP, accessing PrEP, and starting and being adherent to a PrEP regimen.

1) PrEP awareness refers to being aware of PrEP as a prevention tool. This differs from PrEP knowledge, which refers to knowing specific information about PrEP (i.e., efficacy, side effects, and others). Awareness was inquired with the question, "Have you ever heard of pre-exposure prophylaxis to prevent HIV or PrEP?" response options were dichotomic: "1=Yes" or "0=No".

2) PrEP eligibility, that is meeting objectively the criteria for PrEP prescription, was defined as meeting three criteria: 1) participants self-reported being HIV negative, had condomless anal sex in the last six months, AND 2) had either an HIV Incidence Risk Index (HIRI) >1028 or 3) a self-reported history of syphilis, gonorrhea, or chlamydia infection in the last six months. Items used to calculate HIRI scores are presented in Table 1.

3) PrEP willingness, that is, one's self-motivation to use PrEP, which was inquired with the question "If PrEP is effective in reducing the risk of HIV by 90 %, and if in the next 12 months, PrEP was offered for free in Colombia, would you like to use PrEP to prevent HIV?", measured on a 5-point Likert scale where 1 = "definitely yes," 2 = likely yes, 3 = neither yes nor not, 4 = likely not, 5 = "definitely not," those indicating "definitely yes" were coded as willing to take it.

Table 1 Items used to calculate HIRI scores28  

HIRI variable and response options HIRI-Score
Age
<18 years or ≥49 years 0
18- 28 years 8
29- 40 years 5
41-48 years 2
Number of sex partners
0 to 5 0
6 to 9 4
>10 7
Number of episodes CRAI (condomless receptive anal intercourse-Number of episodes), with any partner
0 times 0
1 or more times 10
Number of HIV-infected male partner
None positive partner 0
1 positive partner 4
>1 positive partner 8
Number of episodes of Condomless insertive anal sex, with HIV-infected partner
0 -4 times 0
5 or more times 6
Methamphetamine use
Yes 5
No 0
Popper use
Yes 3
No 0

Source: modified from reference 28

4) Perception of PrEP eligibility, one's perception of being eligible for PrEP, assessed with the question "Do you believe that you are a good candidate to take PrEP?" measured on a 5-point Likert scale where 1 = "I am a candidate" 2 = I am likely a candidate, 3 = neither yes nor not, 4 = likely not a candidate, and 5 = "I am not a candidate"; those indicating themselves as "definitely candidates" were coded as self-perceived as PrEP candidates.

5) Intention to take PrEP assesses the intention to use it if already available, and that was addressed with the question, "If your doctor or other health professional were available to prescribe PrEP for you in the next 12 months, would you start taking PrEP pills?" measured with a 5-point Likert scale where 1 = "I would definitely start taking them" 2 = "likely would start taking", 3 = neither yes nor not, 4 = likely would no start, and 5 = " I would no start taking them"; those indicating they "would begin taking PrEP" were coded as with intention to take PrEP, and

6) PrEP action, which is defined as having had a concrete action of searching or using PrEP, was assessed with two questions, "Have you asked a health professional about PrEP?" and "Have you taken an-tiretroviral (or HIV) medications to prevent HIV infection?", both response options were dichotomic "1 = Yes" or "0 = No"; experience was defined as a "yes" response to any of those items.

Statistical analyses: We used descriptive statistics to summarize the social characteristics of the sample as a whole and by sexual orientation/gender identity groups (MSM vs TGW). We then compared PrEP outcomes by sociodemographic characteristics using the chi2 test, Fisher's exact test in categorical variables, and the Kruskal-Wallis rank test in ordinal measures. The normal distribution of the variables was evaluated using the Shapiro-Wilk test. We follow two approaches to calculate the percentage of participants at each stage of the PrEP cascade. First, we calculate the percentage of participants who meet the criteria for each of the PrEP outcomes, independently of the distribution in the other outcome; we did this for the whole sample (and in each of the sexual orientation/gender identity groups). Then, we calculate the cascade using it as a starting point those eligible for PrEP, among those eligible, those who were aware, among those aware, those willing to start PrEP, and so on. To represent the motivational cascade in multivariate models, we considered that each of the PrEP outcomes represents a stage in the direction towards the decision of PrEP uptake: PrEP awareness precedes willingness, and the latter precedes intention, and so on. Thus, for each of the PrEP outcomes, the relationship with an outcome of the previous stage was examined. Analysis was conducted with the whole sample and in the sample of those eligible for PrEP. Poisson analysis for cross-sectional data has been used extensively even when the outcome is dichotomous, as in the case of our analysis29,30. All analyses were done with Stata/IC version 16. A significance level of less than 0.05 was used for all analyses.

Ethical aspects

This study is classified as "minimum risk research," according to the risk category established in Article 11 of Resolution 8430 of 1993 of the Colombian Ministry of Health. Ethical principles such as autonomy, beneficence, and justice were respected. This study was reviewed and approved by the Research Ethics Boards of Corporación de Lucha contra el SIDA (approval certificate no. 034 of May 16, 2018) and Queen's University (DMED-2326-20). Participants of the online sample were given access to an online consent form. Once consent was granted, a Qualtrics-based survey immediately followed, which could be completed online. Participants in the face-to-face survey were invited to participate in person, and written consent was obtained before starting the survey.

Conflicts of interest

The authors declared no potential conflicts of interest concerning this article's research, authorship, and/or publication of this article.

Results

A total of 301 online participants who resided in Colombia, most of whom were MSM and who self-reported as HIV negative, completed at least 80 % of the survey and composed the online sample. This corresponds to 51.5 % (301/584) of those who accessed the questionnaire. The face-to-face questionnaire was completed by 93 % of those invited to participate. Exclusions from the analysis were related to having reported living with HIV (n=84), being a Cis-woman (n=8), residing abroad (n=6), and answering less than 80 % of the questionnaire (n=53) (Figure 1).

Source: authors.

Figure 1 Flow of participants according to participation in the study.  

The baseline demographic characteristics are shown in Table 2. A total of 552 participants were MSM (78 %), 301 (42 %) were recruited online, 251 (35 %) were recruited face-to-face, and 158 (22.2 %) were TGW, all of whom were recruited face-to-face. Participants had an average age of 30 years (range: 18-77 years); 31 % were less than 24 years old; had medium-high education levels, with 56 % having more than secondary education; 83 % reported being single, 56 % working, 21 % had incomes above two minimum monthly wages (minimum wage was approx. 255.66 USD per month), 87 % had health insurance, and 6 % resided in neighborhoods of high socioeconomic status. TGW were more likely to be of lower socioeconomic conditions compared to MSM, either because of education, income, or socioeconomic stratum (Table 2). Differences in socioeconomic conditions were also observed between the sample of MSM recruited online and face-to-face, with lower status observed in the face-to-face sample.

Table 2 Baseline demographic characteristics of the study participants. 

Groups
All (n=710) MSM interviewed face to face (n=251(35.3%)) MSM completed online survey (n=301(42.4%)) TGW** interviewed face to face (n=158(22.2%)) p-value
Age, years (means; standard deviation) 30.3; 10.0 28.0; 9.9 31.2; 9.0 32.4; 11.3 <0.001
n (%) n (%) n (%)
Civil status
Married - Free Union 112 (15.7) 38 (15.1) 48 (15.9) 26 (16.5) 0.079
Single 589 (83.0) 212 (84.5) 245 (81.4) 132(83.5)
Separated-widowed 9 (1.3) 1 (0.4) 8 (2.7) 0 (0.0)
Living arrangements
Alone 184(26.0) 50 (20.0) 64 (21.3) 70 (44.3) <0.001
Family 439(62.0) 170 (68.0) 202 (67.3) 67 (42.4)
Friends-others 85(12.0) 30 (12.0) 34 (11.3) 21 (13.3)
Education level *
Primary school 44 (6.2) 7 (2.8) 1 (0.3) 36 (22.8) 0.0001
Secondary school 270 (38.0) 132 (52.6) 30 (9.9) 108 (68.4)
Technical-superior 396 (55,8) 112 (44,6) 270 (89,7) 14 (8,8)
Socioeconomic stratum *
One-two (very low-low) 333 (46.0) 131(52.4) 85 (28.2) 117 (74.0) 0.0001
Three-Fourth (Middle) 330 (46.5) 111 (44.4) 178 (59.1) 41 (26.0)
Five-Six (High) 46 (6.5) 8 (3.2) 38 (12.6) 0(0.0)
Occupation status (one or more options)
Work * 397 (55.9) 129 (51.4) 191 (63.5) 77 (48.7) 0.002
Housekeepers* 13 (1.8) 1 (0.4) 10 (3.3) 2 (1.3) 0.029
Voluntary 28 (3.9) 9 (3.6) 11 (3.6) 8 (5.1) 0.714
Student* 132 (18.6) 64 (25.5) 61 (20.3) 7 (4.4) <0.001
Unemployed 141 (19.8) 49 (19.5) 67 (22.3) 25 (15.8) 0.256
Other* 83 (11.7) 21(8.4) 18 (5.9) 44 (27.8) <0.001
Current monthly income *
No income 132 (18.6) 54 (21.5) 49 (16.3) 29 (18.4) 0.0001
<1 minimum salaries*** 210 (29.6) 90 (35.9) 60 (19.9) 60 (38.0)
Between 1 to 2 219 (30.8) 83 (33.1) 73 (24.2) 63 (39.9)
>2 minimum salaries*** 149 (21.0) 24 (9.6) 119 (39.5) 6 (3.8)
Health insurance/coverage (Yes) 614 (86.6) 223 (88.8) 258 (86.0) 113 (84.2) 0.371
PrEP awareness (yes) * 361 (51.2) 106 (42.2) 213 (71.9) 42(26.6) <0.001

*Differences observed between the sample of MSM recruited online and face-to-face 0.001 < p-value < 0.014.

** Difference observed between the sample of TGW and MSM interviewed face to face (age, coexistence, education level, socioeconomic stratum, occupation status, and PrEP awareness; p s 0.001); difference observed between the sample of TGW and MSM online survey (age, coexistence, education level, socioeconomic stratum, income, occupation status, and PrEP awareness; p s 0.001).

***Current monthly income in dollars is approximately $ 256.

Source: own creation.

PrEP motivational cascade outcomes in the whole sample.

Fifty-one percent of the participants were aware of PrEP, 58.7 % were willing to use PrEP, 45 % were self-perceived as PrEP candidates, 56.2 % had the intention to take PrEP, and 23 % had acted around PrEP.

TGW reported the lowest level of awareness, while the MSM interviewed in person reported the lowest levels of willingness, perception of being PrEP eligible, and intention to use PrEP (Figure 2 and Table 3). There were differences in awareness (p < 0.001), willingness (p < 0.001), perception of being a PrEP candidate (p < 0.001), intention (p < 0.001), and action (p = 0.05) across the sex orientation/gender identity groups.

Source: own creation.

Figure 2 Distribution of PrEP outcomes in the whole sample. In evaluating PrEP motivational cascade outcomes categories, bars represent percentages of the total individuals sampled per study group for each outcome.  

In bivariate analysis, PrEP eligibility was related to willingness, intention to take, and experience with PrEP (see Table 3). PrEP awareness was related to willingness and intention in that being aware of PrEP was related to a greater likelihood of both being willing and having the intention to take PrEP; in turn, willingness was associated with having an intention and experience with PrEP. Neither age nor having a stable relationship was related to any of the PrEP outcomes. The socioeconomic status of participants, irrespectively of the way it was measured (education, income, occupation, or neighborhood socioeconomic strata), was related to PrEP outcomes: those with lower socioeconomic status were more likely to be classified as eligible and were more likely to be aware, less willing to take, have less intention to take or have had an experience with PrEP (Table 3). Those without health insurance were likelier to be eligible and less likely to be aware of or have taken action around PrEP. Having health insurance coverage was not related to any other PrEP outcome. The multivariate analysis showed that the differences between sex orientation/gender identity groups and the negative effects of the low socioeconomic status variables on the PrEP outcomes remained (Table 4).

Table 3 Bivariate associations with PrEP outcomes using Generalized Linear Model-Poisson in all samples. 

Outcome (IRR*; IC95 %) Eligibility, yes vs. no Awareness, yes vs. no Willing to take Prep, yes vs. no Self-perceived as prep candidate, yes vs. no Intention, yes vs. no Action, yes vs. no
Group
MSM interviewed face to face 1 1 1 1 1 1
MSM completed online survey 1.02 (0.87-1.19) 1.70 (1.45-2.00) 1.65 (1.40-1.94) 1.79 (1.43-2,23) 1.56 (1.31-1.86) 1.41 (1.02-1.93)
TGW interviewed face to face 1,06 (0,88-1,27) 0.63 (0.47-0.85) 1.46 (1.21-1.75) 1.84 (1.45-2.33) 1.63 (1.36-1.97) 0.98 (0.66-1.47)
p-value 0.8224 < 0.001 < 0.001 < 0.001 < 0.001 0.0463
Eligibility, yes vs. no AA 1.13 (0.98-1.31) 1.18 (1.04-1.35) 1.26 (1.06-1.50) 1.18 (1.03-1.36) 1.67 (1.23-2.26)
Awareness, yes vs. no AA AA 1.37 (1.20-1.56) 1.44 (1.22-1.71) 1.26 (1.09-1.44) 5.82 (3.84-8.83)
Willing, yes vs. no ** ** ** ** ** **
Self-perceived as candidate, yes vs. no ** ** ** ** ** **
Age, years(IRR ; IC95 %) 0.98 (0.98-0.99) 0.99 (0.99-1.00) 0.99 (0.98-1.00) 0.99 (0.98-1.00) 0.99 (0.98-1.00) 1.00 (0.99-1.02)
18-30 1 1 1 1 1 1
31-45 0.79 (0.66-0.94) 0.97 (0.82-1.14) 0.87 (0.75-1.02) 0.92 (0.76-1.13) 0.87 (0.74-1.03) 1.28 (0.95-1.72)
>45 0.65 (0.48-0.89) 0.77 (0.57-1.03) 0.90 (0.72-1.14) 0.97 (0.73-1.30) 0.92 (0.72-1.17) 0.77 (0.43-1.35)
p-value 0.0014 0.2189 0.2034 0.7493 0.2514 0.1253
Civil status
Married - Free Union 1 1 1 1 1 1
Single 0.88 (0.74-1.04) 1.02 (0.83-1.24) 0,90 (0,77-1.06) 0.91 (0.73-1.13) 0,98 (0.82-1.17) 1.07 (0.72-1.58)
Separated-widowed 0.74 (0.35-1.57) 0.99 (0.48-2.03) 1.12 (0.68-1.83) 1.18 (0.60-2.30) 1.25 (0.76-2.05) 0.65 (0.10-4.15)
p-value 0.2942 0.9824 0.3255 0.5392 0.5882 0.8304
Education level
Primary school 1 1 1 1 1 1
Secondary school 0.69 (0.56-0.86) 0.95 (0.60-1.53) 0.76 (0.58-1.00) 0.75 (0.55-1.04) 0.78 (0.61-1.01) 0.68 (0.37-1.26)
High school 0.74 (0.60-0.91) 2.13 (1.37-3.30) 1.09 (0.85-1.39) 0.92 (0.68-1.25) 0.94 (0.74-1.19) 1.25 (0.71-2.21)
p-value 0.0032 < 0.0001 <0.0001 0.0597 0.0344 0.0012
Socioeconomic stratum
One-two (very low-low) 1 1 1 1 1 1
Three-Fourth (middle) 0.97 (0.84-1.12) 1.64 (1.39-1.93) 1.07 (0.94-1.23) 1.10 (0,92-1.31) 0.99 (0,86-1,13) 1.16 (0.85-1.56)
Five-Six (high) 0.87 (0.63-1.19) 2.20 (1.81-2.67) 1.38 (1.14-1.67) 1.32 (0.98-1.77) 1.14 (0.89-1.46) 2.67 (1.86-3.83)
p-value 0.6721 < 0.0001 0.004 0.1613 0.4919 <0.0001
Occupation status (one or more options)
Some kind of Any job vs. no work 1.06 (0.93-1.22) 0.78 (0.67-0.91) 0.86 (0.76-0.98) 0.82 (0.69-0.98) 0.91 (0.79-1.04) 0.91 (0.79-1.04)
Current monthly income
No income 1 1 1 1 1 1
<1 0.91 (0.76-1.10) 1.05 (0.81-1.36) 1.10 (0.89-135) 0.99 (0.76-1.29) 1.00(0.82-1.23) 0.84 (0.53-1.33)
Between 1 to 2 0.85 (0.71-1.03) 1.19 (0.93-1.53) 1.13 (0.92-1.39) 1.10 (0.85-1.42) 1.03 (0.84-1.26) 1.04 (0.68-1.61)
>2 0.84 (0.68-1.04) 1.91 (1.52-2.39) 1.31 (1.07-1.61) 1.30 (1.01-1.69) 1.15 (0.94-1.42) 1.71 (1.13-2.57)
p-value 0.3145 < 0.0001 0.0355 0.0661 0.3902 0.0007
Health insurance/coverage (Yes) 1.19 (0.99-1.41) 0.77 (0.60-1.00) 0.98 (0.82-1.19) 0.93 (0.71-1.20) 1.01 (0.83-1.23) 0.51 (0.28-0.89)

*IRR: incidence rate ratio- calculated using GLM-Poisson Multivariate. **: not applicable.

Source: own creation.

Table 4 Multivariate associations with PrEP outcomes using Generalized Linear Model-Poisson in all samples. 

Outcome (IRR*; IC95 %) Eligibility, yes vs. no Awareness, yes vs. no Willing to take Prep, yes vs. no Self-perceived as prep candidate Intention Action
Group
MSM Survey face to face 1 1 1 1
MSM Survey Online 1.35 (1.13-1.60)** 1.38 (1.15-1.65)** 1.50 (1.16-1.93)** 1.37 (1.12-1.67)**
TGW 0.78 (0.55-1.09) 1.70 (1.37-2.10)** 2.11 (1.61-2.75)** 1.82 (1.48-2.24)**
Eligibility, yes vs. no 1.18 (0.99-1.40)*** 1.55 (1.17-2.04)**
Awareness, yes vs. no 0.22 (1.06-1.41)** 1.37 (1.13-1.65)** 1.20 (1.03-1.40)** 5.67 (3.65-8.83)**
Age, years
18-30 1 1 1 1 1
31-45 0.77 (0.65-0.92)** 0.88 (0.76-1.03) 0.82 (0.71-0.96)** 0.83 (0.70-0.98)** 1.36 (1.03-1.80)**
>45 0.63 (0.45-0.86)** 0.78 (0.59-1.02)*** 0.89 (0.69-1.13) 0.89 (0.69-1.14) 0.96 (0.62-1.48)
Civil status
Married - Free Union 1
Single 0.86 (0.73-1.02)***
Separated-widowed 0.89 (0.44-1.82)
Education level
Primary school 1
Secondary school 0.65 (0.52-0.82)**
High school 0,73 (0,55-0,96)**
Socioeconomic stratum
One-two (very low-low) 1 1
Three-Fourth (Middle) 1.26 (1.06-1.49)** 0.87 (0.65-1.18)
Five-Six (high) 1.36 (1.09-1.68)** 1.72 (1.12-2,62)**
Current monthly income
No income 1
<1 1.10 (0.85-1.43)
Between 1 to 2 1.19 (0.89-1.58)
>2 1.35 (0.99-1.84)***

*IRR: incidence rate ratio- calculated using GLM-Poisson Multivariate. ** p-value <0.05. *** 0.05 < p < 0.10.

Source: own creation.

PrEP motivational cascade outcomes in PrEP-eligible participants.

Table 5 presents the distribution of variables that determined eligibility for PrEP. Overall, 39.4 % of the MSM online, 49.4 % of the MSM face-to-face participants, and 51.5 % of TGW were eligible for PrEP. A total of 35.5 % of participants reported a high number of sexual partners, 43.3 % used poppers, 80.3 % reported condomless receptive anal intercourse, and 18.4 % reported a sexually transmitted infection in the previous six months. MSM and TGW eligibility criteria seem to differ in two aspects: having HIV-infected male partners and number of partners; nearly 90 % of the sample reported having no HIV-positive partners.

Table 5 Contribution of variables to individual scores of HIRI. 

HIRI variable and response options HIRI-Score All MSM interviewed face to face MSM completed online survey TGW interviewed face to face
Age n(%) n(%) n(%) n(%)
<18 years or ≥49 years 0 53 (7.5) 15 (5.9) 18 (5.9) 20 (12.7)
18- 28 years 8 56 (7.9) 10 (3.9) 30 (9.9) 16 (10.1)
29- 40 years 5 221 (31.1) 62 (24.7) 111 (36.9) 48 (30.4)
41 -48 years 2 380 (53.5) 164 (65.3) 142 (47.2) 74 (46.8)
p-valueA 0,0001
Number of sex partners
0-5 0 489 (68.9) 195 (77.7) 207(68.8) 87 (55.1)
6 to 9 4 89 (12.5) 29 (11.5) 43 (14.3) 17 (10.8)
>10 7 132 (18.6) 27 (10.8) 51 (16.9) 54 (34.1)
p-valueA 0.0001
Number of episodes CRAI (condomless receptive anal intercourse-Number of episodes), with any partner
0 times 0 404 (56.9) 142 (56.6) 175 (58.1) 87 (55.1)
1 or more times 10 306 (43.1) 109 (43.4) 126 (41.9) 71 (44.9)
p-valueA 0.815
Number of HIV-infected male partner
None positive partner 0 657 (92.5) 234 (93.2) 269 (89.4) 154 (97.5)
1 positive partner 4 44 (6.2) 13 (5.2) 27 (8.9) 4 (2.5)
>1 positive partner 8 9 (1.3) 4 (1.6) 5 (1.7) 0 (0)
p-valueA 0.021
Number of episodes of Condomless insertive anal sex, with HIV-infected partner
0 -4 times 0 698 (98.3) 244 (97.2) 298 (99.0) 156 (98.7)
5 or more times 6 12 (1.7) 7 (2.8) 3 (1.0) 2 (1.3)
p-valueA 0.289
Methamphetamine use
Yes 5 8 (1.1) 5 (1.9) 2 (0.7) 1 (0.6)
No 0 702 (98.9) 246 (98.1) 299 (99.3) 157 (99.4)
p-valueA 0.385
Popper use
Yes 3 230 (32.4) 82 (32.7) 86 (28.6) 62 (39.2)
No 0 480 (67.6) 169 (67.3) 215 (71.4) 96 (60.8)
p-valueA 0.068
Report condomless anal sex within the last 6 months
Yes na 291 (41.0) 150 (59.8) 184 (61.1) 85 (53.8)
No na 419 (59.0) 101 (40.2) 117 (39.9) 73 (46.2)
p-valueA 0.301
(Infectious syphilis or gonorrhea, chlamydia) STI, particularly if diagnosed in the preceding 6 months
Yes na 70 (9.9) 21 (8.4) 33 (10.9) 16 (10.1)
No na 640 (90.1) 230 (91.6) 268 (89.0) 142 (89.9)
p-valueA 0.61

*p-value: comparing the three groups. *na: not applicable.

Source: own creation.

Assuming the PrEP-eligible participants were the starting point (100 %) of the motivational cascade, the outcomes were depicted in Figure 3. Most PrEPeligible individuals are lost in the awareness stage, which was more pronounced in TGW, in whom we observed that only 29.5 % were aware of PrEP from those eligible. The highest awareness among eligible people was observed in the MSM-online sample, 73 %, in which the experience with PrEP was the highest at 23 %.

Source: own creation.

Figure 3 Distribution of PrEP cascade in the eligible sample. 

Bivariate and multivariate results on the relations between sociodemographic conditions and PrEP outcomes are in the same direction as in the whole sample (tables 6 and 7): high levels of education, income, and socioeconomic status were related to greater awareness, willingness, intention, and action. In multivariate analysis, socioeconomic conditions remain important in terms of awareness and willingness. Having health insurance was not related to any outcome in the final models.

Table 6 Bivariate associations with prep outcomes using generalized linear model-Poisson in the sample eligible for PrEP. 

Outcome (IRR; IC95 %) Awareness, yes vs. no Willing to take Prep, yes vs. no Self-perceived as prep candidate Intention Action
Group
MSM interviewed face to face 1 1 1 1 1
MSM completed Online Survey 1.56 (1.27-1.91) 1.52 (1.25-1.85) 1.70 (1.31-2.21) 1.65 (1.32-2.05) 1.40 (0.97-2.01)
TGW interviewed face to face 0.63 (0.43-0.91) 1.25 (0.98-1.58) 1.40 (1.02-1.92) 1.53 (1.19-1.95) 0.77 (0.46-1.30)
p-value <0.0001 0.0001 0.0003 <0.0001 0.0239
Eligibility, yes vs. no ** ** ** ** **
Awareness, yes vs. no 1.37 (1.16-1.61) 1.58 (1.26-1.97) 1.29 (1.09-1.54) 5.18 (3.11-8.61)
Willing, yes vs. no ** ** ** ** **
Self-perceived as candidate, yes vs. no ** ** ** ** **
Age, years(IRR; IC 95 %) 0.99 (0.99-1.01) 0.99 (0.98-1.00) 0.99 (0.98-1.01) 0.99 (0.98-1.01) 1.01 (0.99-1.02)
18-30 1 1 1 1 1
31-45 0.97 (0.82-1.14) 0.88 (0.72-1.08) 0.96 (0.75-1.23) 0.94 (0.76-1.15) 1.41 (0.99-1.98)
>45 0.77 (0.57-1.03) 0.91 (0.66-1.26) 0.88 (0.57-0.137) 0.97 (0.70-1.34) 0.71 (0.31-1.60)
p-value 0.1773 0.4331 0.8256 0.8152 0.0785
Civil status
Married - Free Union 1 1 1 1 1
Single 0.97 (0.77-1.24) 0.95 (0.78-1.15) 0.97 (0.74-1.26) 0.98 (0.79-1.21) 1.05 (0.68-1.62)
Separated-widowed 0.90 (0.33-2.47) 1,14 (0.63-2.06) 0.98 (0.36-2.70) 1.23 (0.67-2.23) 0.93 (0.16-5.33)
p-value 0.9675 0.7116 0.9731 0.7354 0.9699
Education level
Primary school 1 1 1 1 1
Secondary school 1,28 (0,70 - 2,33) 0.78 (0.57-1.08) 0.96 (0.62-1.50) 0.83 (0.61-1.14) 0,91 (0.40-2.05)
High school 2.47 (1.41- 4.33) 1.15 (0.87-1,52) 1,26 (0,83-1,89 1,04 (0,78-1,39) 1,93 (0,92-4,06)
p-value <0.0001 0.0004 0.0641 0.0596 0.0007
Socioeconomic stratum
One-two (very low-low) 1 1 1 1 1
Three-Fourth (Middle) 1.54 (1.25-1.89) 1.06 (0.90-1.25) 1.12 (0.90-1.39) 0.91 (0.76-1.08) 1.17 (0.82-1.67)
Five-Six (high) 2.22 (1.78-2.76) 1.45 (1.18-1.78) 1.60 (1.18-2.17) 1.32 (1.05-1.66) 2.90 (1.97-4.27)
p-value <0.0001 0.0013 0.0089 0.0071 <0.0001
Occupation status (one or more options)
Some kind of job vs. no work 0.77 (0.64-0.94) 0.86 (0.73-1.00) 0.77 (0.62-0.95) 0.94 (0.80-1.11) 0.71 (0.51-1.00)
p-value 0.01 0.059 0.017 0.467 0.05
Current monthly income
No income 1 1 1 1 1
<1 1.14 (0.82-1.59) 1.39 (1.06-1.82) 1.21 (0.86-1.69) 1.12(0.87-1.45) 0.73 (0.42-1.25)
Between 1 to 2 1.34 (0.98-1.84) 1.41 (1.08-1.85) 1.30 (0.93-1.80) 1.18 (0.91-1.51) 1.02 (0.62-1.67)
>2 1.97 (1.48-2.64) 1.54 (1.17-2.02) 1.56 (1.12-2.17) 1.23 (0.94-1.60) 1.89 (1.21-2.96)
p-value <0.0001 0.023 0.0441 0.4676 0.0001
Health insurance/coverage (Yes) 0.79 (0.58-1.07) 0.99 (0.79-1.23) 1.01 (0.77-1.34) 1.00 (0.80-1.26) 0.51 (0.27-0.96)
p-value 0.129 0.902 0.913 0.975 0.036

*IRR: incidence rate ratio- calculated using GLM-Poisson Multivariate; **: not applicable.

Source: own creation.

Table 7 Multivariate association with PrEP outcomes using generalized linear model-Poisson in the eligible sample to PrEP. 

Outcome (IRR*; IC 95 %) Awareness, yes vs. no Willing to take Prep, yes vs. no Self-perceived as prep candidate Intention Action
Group
MSM Survey face to face 1 1 1 1
MSM Survey Online 1.30 (1.05-1.62)** 1.33 (1.08-1.63)** 1.48 (1.10-1.97)** 1.51 (1.19-1.92)**
TGW 0.82 (0.54-1.26) 1.38 (1.04-1.82)** 1.56 (1.10-2.22)** 1.68 (1.27-2.23)**
Awareness, yes vs. no 1.23 (1.02-1.47)** 1.46 (1.14-1.86)** 1.23 (1.02-1.48)** 4.76 (2.80-8.07)**
Age, years
18-30 1
31-45 0.89 (0.73-1.09)
> 45 0.57 (0.35-0.91)**
Education level
Primary school 1 1
Secondary school 0.94 (0.48-1.86) 1.19 (0.85-1.66)
High school 1.33 (0.99-1.78)*** 1.31 (1.02-1.69)**
Socioeconomic stratum
One-two (very low-low) 1
Three-Fourth (Middle) 1.26 (1.03-1.56)**
Five-Six (Hight) 1.52 (1.18-1.96)**
Current monthly income
No income 1
<1 1.36 (1.06-1.76)**
Between 1 to 2 1.33 (1.02-1.74)**
>2 1.21 (0.92-1.60)

*IRR: incidence rate ratios- calculated using GLM-Poisson Multivariate; **p-value<0.05; *** 0.05 < p < 0.10

Source: own creation.

Discussion

This study is the first in Colombia to use the motivational PrEP cascade proposed by Parsons et al25, including PrEP eligibility, awareness, willingness, and intention in persons who self-identified as MSM or TGW. We found a high proportion, nearly 50 % of participants in this sample, of PrEP-eligible individuals, suggesting a high need to implement this intervention in Colombia, similar to what has been found in many other countries with similar HIV epidemics31,32. Other studies in Latin American populations reported identical figures in terms of PrEP eligibility in MSM and TGW: around 66 % of TGW in Brazil33, and between 51 % - 54 % of MSM at high risk of HIV acquisition in Brazil, Mexico, and Peru32. Other studies involving Latino populations also show that high proportions of TGW and MSM participants are PrEP eligible (eligibility adapted from the WHO criteria for pre-exposure prophylaxis or criteria from the CDC/Brazilian recommendations)26,33,34. Although the estimated HIV acquisition risk in MSM and TGW in our study is high, this may still be an underestimation given the lack of awareness from participants of their sexual partners' HIV serostatus and underreporting of asymptomatic STIs (e.g., latent stages of syphilis, health system limitations on extra-genital Chlamydia and Gonorrhea testing), which would have potentially increased eligibility if known. In addition, recall bias (e.g., not remembering how many partners they had sex with during the last six months) or the Hawthorne effect in participants interviewed face-to-face (e.g., minimizing the report on the number of sex partners while being observed) may also favor under-reporting risk.

Our results support the pertinence of the cascade concept to describe the status of PrEP uptake in MSM and TGW. In this regard, we found that PrEP awareness predicted willingness. In turn, willingness increased the likelihood of intention to take PrEP.

Participants with previous experience with PrEP reported more awareness of and willingness to take PrEP. This has been described in previous studies in Latin America26,35. The concept of a cascade to describe people at different stages of intervention uptake has been widely used for HIV treatment and to delineate population policy goals for HIV36,37. Similarly, the cascade provides a snapshot of how PrEP is perceived by a population sample expected to be a target for such an intervention. In this sample, 293 MSM and 88 TGW were eligible for PrEP, but most participants who completed the survey face-to-face needed to be made aware of its existence. Interestingly, more people were willing to take PrEP than those aware of the intervention. This is likely so because PrEP awareness was low in Colombia at the time of this survey (in the absence of a formal PrEP campaign), and the question about willingness in this survey was posed after an introductory paragraph that highlighted the expected PrEP benefit assuming no cost to the user. These observations suggest that, in Colombia, PrEP campaigns need to emphasize PrEP awareness with key messages such as the expected benefit, ease of use, and safety and make efforts towards eliminating or reducing costs to users.

While PrEP has demonstrated efficacy in a wide variety of populations with a high risk of HIV acquisition, including MSM, TGW, heterosexual individuals, and people who inject drugs8-10,38, MSM and TGW are expected to be a significant proportion of PrEP users in Colombia since these are two populations with the highest HIV prevalence in this country39. PrEP awareness in this study was 51.2 % overall, with a higher proportion of MSM being PrEP aware (completed online survey 71.9 % and interviewed face to face 42.2 %) than TGW (26.6 %). This level of awareness is comparable to that of other LA countries (Supplementary Table 1): An extensive multi-country Latin American survey in MSM found 10.4 % of PrEP awareness in 201240. This level increased over time in Brazil, with 51.5 % in 201741 and 64.9 % in 201826. PrEP awareness in MSM was 46.6 % in Peru and 64 % in Mexico in 201826. These figures are much lower than those reported in US samples in 2017 (95 %) and Canada in 2016 (80 %)42,43. Factors linked to the formal adoption of PrEP by the health systems in North America likely explain the much higher awareness of target populations in those settings. PrEP awareness in TGW in our sample was much lower than that of MSM. Lower PrEP awareness has been described consistently in TGW in Latin America and the United States33,44,45. TGW are consistently more socially vulnerable and marginalized across countries, with Colombia being no exception39,46. Despite this, TGW expressed a higher willingness to take PrEP, a finding that has also been demonstrated elsewhere33,47,48. These two observations suggest that this population group would significantly benefits from PrEP implementation. The qualitative results from PrEP-COL49 indicate that TGW perceived PrEP "as a need" and "as useful" along with condoms in cases of power imbalance in the context of sex work or with casual sex with men who do not want to use a condom50. Notably, online advertisement was ineffective at reaching TGW in our study, while strategies led by LGTBQ community leaders proved more suitable. This highlights that the socialization of PrEP campaigns requires adjustments suitable for the various population groups of interest.

Other social disparities in PrEP eligibility, awareness, and uptake have also been described. People with higher levels of stigma use less PrEP.

Racial disparities have been described in the US, where African Americans and Hispanics are less likely to use PrEP51. In Australia52, the UK53, and France54, MSM with social disadvantages were less likely to have the knowledge and to take PrEP. Similar results were found in MSM in Canada55. Our study has also demonstrated that PrEP eligibility, awareness, and willingness to use PrEP are highly inequitable in Colombia as the more educated, those with higher income, or those living in a higher SES neighborhood were more likely to have PrEP-positive cascade outcomes. Efforts to increase access to low SES MSM and TGW to PrEP information are a sensitive need in Colombia. Using social media to disseminate information about PrEP seems to reach individuals with higher SES but will likely miss reaching a large proportion of MSM and TGW.

This study is not free of limitations. This study collected information in two non-probabilistic sampling strategies. The study had to adapt to the COVID-19 epidemic, so it started with online surveys, which others have successfully used. However, the study population recruited online was mainly composed of MSM and no TGW, which required targeted advertisement via community organizations and face-to-face interviews during COVID-19 low-incidence periods. This study's sample of MSM and TGW seems similar to a sample previously recruited in three large cities in Colombia using respondent-driven sampling (Supplementary Table 2)3,4. To confirm the veracity of the information in the online survey, we asked various questions that allowed us to assess consistency, such as gender, sex, sex with women, sex with men, etc. We have used 6 to 12-month recall periods, which allows for the introduction of recall bias, but landmark studies have employed similar recall periods, which makes them comparable20.

Supplementary Table 1 Comparative studies of awareness, willingness, and intention to take PrEP in Latin American countries. 

Author Country Sample Eligibility Awareness Willingness Intention Year of Data collection
MSM
Torres TS, Konda KA, Vega-Ramirez EH, Elorreaga O A, Diaz- Sosa D, Hoagland B, et al (2019)18. Brazil, Mexico and Peru. Participants accessing the questionnaire: N=43.687. 67.50 % 64.92 % 64.23 % No data: Willingness is understood as an intentional behavior based on 2 principles: recognition of the behavioral objective (ie, taking PrEP) and strategies implemented to achieve this objective. 2018.
Individuals who completed the questionnaire and were included in the analysis: N=19,457 (44.54 %)
Hoagland B, De Boni RB, Moreira RI, Madruga JV, Kallas EG, Goulart SP, et al (2017)37. Brazil. The final study sample consisted of 1187 individuals, 95,3 % were male and 4,7 % were trans women. Not reported. 61.30 % 82.10 % No data: they have measured intention to use PrEP as a proxy of willingness. 2014-2015.
Yi S, Tuot S, Mwai GW, Ngin C, Chhim K, Pal K, et al (2017)25. Systematic review: studies related to Latin America
145 countries in Africa, Asia, Europe and Latin America. 2774 MSM. Not reported. 69.80 % 80.80 % Not reported. 2012.
Peru, India and South Africa. 383 MSM. Not reported. Not reported. 69 % Not reported. 2010-2011.
Brazil. 1131 MSM. Not reported. 61.3 % 82.1 % Not reported. 2014-2015.
Perú. 532 MSM and TG. Not reported. Not reported. 96.2 % Not reported. 2008.
Edeza A, Galárraga O, Santamaria EK, Sosa-Rubí S, Operario D, Biello KB (2020). Mexico. A total of 23 participants completed in-depth semi-structured interviews. Not reported. Almost all participants stated that they were unfamiliar with PrEP prior to the interview. Among the participants, most expressed interest in the medication after receiving information about it during the interview. Not reported.
Edeza A, Galarraga O, Novak D, Mayer K, Rosenberger J, Mimiaga M, et al (2019)28. Latin America. We carried out a multinational online survey of MSM in Latin America (n = 22698) in 2012. Not reported. 10.40% Not reported. Not reported. 2012.
Torres TS, Luz PM, De Boni RB, de Vasconcellos MT, Hoagland B, Garner A, et al (2019)29. Brazil. Of 7242 individuals, 4 136 (57 %) completed the questionnaire. Not reported. 51.5 % 56.3 % Finally, they have measured intention to use PrEP, PEP, condoms, and HIVST as a proxy of willingness. 2017.
TGW
Jalil EM, Grinsztejn B, Velasque L, Makkeda AR, Luz PM, Moreira RI, et al (2018)23. Brazil. A total of 374 individuals returned with a recruitment coupon, 370 consented with their participation and were screened (98,9 %) and 345 (93,2 %) eligible transwomen participated in the study. 66.8 % 38 % 74.4 % Not reported. 2015-2016.
Poteat T, Wirtz A, Malik M, Cooney E, Cannon C, Hardy WD, et al (2019)44. EEUU (Baltimore and Washington, DC). Participant TGW, N=201. Not reported. 86.6 % 75 % No reported. 2015-2017.
Zalazar V, Arístegui I, Kerr T, Marshall BD., Romero M, Sued O, et al (2016)45. Argentina. The original study included 452 transgender women. The final analytic sample included a total of 337 (74,6 %) transgender women (278 self-reported HIV negative and 59 with unknown HIV status). Not reported. Not reported. 89.3 % Not reported. 2013.
Hoagland B, De Boni RB, Moreira RI, Madruga JV, Kallas EG, Goulart S, et al (2017)37. Brazil. The final study sample consisted of 1 187 individuals, 95,3 % were male and 4,7 % were trans women. Not reported. 61.3 % 82.1 % No data: they have measured intention to use PrEP as a proxy of willingness. 2014-2015.

*MSM: Men who have Sex with Men. *TG: Transgender. *PrEP: Pre-Exposure Prophylaxis. *PEP:(?), HIVST: Human Immunodeficiency Virus Self Testing. *TGW: Transgender Women. *HIV: Human Immunodeficiency Virus.

Source: own creation.

Supplementary Table 2 Comparative table with sample of MSM and TGW recruited by Berbesy et al. 

Transgender women Transgender women Men who have sex with men Men who have sex with men
Berbesy F, 20194. Study PrEP Col. Berbesy F, 20193. Study PrEP Col.
Sample Medellín Bogotá Cali Medellín Bogotá Cali Medellín Bogotá Cali Medellín Bogotá Cali
n=217 n=248 n=203 n=49 n=68 n=41 n=447 n=439 n=413 n=186 n=194 n=133
Sociodemographic characteristics
Age (years)
18-24 38.9 % 21.9 % 51.9 % 44.9 % 23.5 % 14.6 % 58.7 % 52.5 % 37 % 39.5 % 28.9 % 40.5 %
25-34 43.2 % 36.8 % 34.6 % 38.8 % 44.1 % 41.5 % 30.2 % 31.4 % 28.8 % 42.2 % 43.3 % 45 %
35-44 6.1 % 13.3 % 6.9 % 8.2 % 14.7 % 14.6 % 7.4 % 6.2 % 11.9 % 10.3 % 17 % 8.4 %
>45 11.7 % 28 % 6.6 % 8.2 % 17.7 % 29.3 % 3.7 % 9.9 % 22.3 % 8.1 % 10.8 % 6.1 %
Socioeconomic stratum
0 to 3 86 % 97 % 87.1 % 95.9 % 100 % 95.1 % 88.2 % 87.9 % 86 % 79.6 % 79.8 % 72.2 %
4 to 6 6.1 % 2.8 % 11.2 % 4.1 % 0 % 4.9 % 11.8 % 12.1 % 14 % 20.4 % 20.2 % 27.8 %
Missing 7.9 % 0.2 % 1.7 % 0 % 0 % 0 %
Education level
None or Primary school 13.7 % 14.7 % 15 % 24.5 % 25 % 17.1 % 2.3 % 3.9 % 6 % 8.1 % 13.4 % 8.3 %
Less than secondary school 46.90% 48.50% 26.80 %
Secondary school 74.70% 70.90 % 67.60 % 22.50% 19.10% 41.50 % 30.10% 23.00 % 48.80 % 25.80% 20.10 % 21.10 %
Technical 10.10% 6.60% 11.60 % 6.10 % 5.90% 12.20 % 8.50 % 17.80 % 26.20 % 19.40% 18.60 % 24.10 %
Some university studies 0.00 % 1.50% 0.00% 11.30% 10.30 % 8.30%
University - postgraduate 1.60 % 7.80% 5.60% 0.00 % 0.00% 2.40% 49.10% 55.20 % 19.10 % 29.00% 24.70 % 24.10 %
Civil status
Single 88.50% 74 % 76.40 % 81.60% 82.40% 87.80 % 88.10% 85 % 83.80 % 89.30% 81.40 % 76.70 %
Married - Free Union 11.60% 20.20 % 21.60 % 18.40% 17.70% 12.20 % 11.30% 14.40 % 15.10 % 9.20 % 18.00 % 21.80 %
Separated/divorced 4.10% 0.00 % 0.00% 0.00% 0.70 % 0.60% 11 % 1.10 % 0.00% 0.80%
Widowed 1.90% 2 % 0.00 % 0.00 % 0.00% 0.50 % 0.5 % 0.8 %
Coexistence
Alone 35.90% 59.50 % 26.50 % 30.60% 58.80% 36.60 % 10.70% 20.40 % 27.10 % 30.60% 58.80 % 36.60 %
Family / non family 76.70% 44.60 % 61.30 % 55.10% 23.50% 61.00 % 78.80% 65.90 % 61.70 % 55.10% 25.00 % 61.00 %
Sons 3.00 % 9.70% 0.00 % 1.50% 0.00%
Husband/Permanent Partner 11.90% 33.80 % 20.60 % 14.30% 16.20% 2.40% 10.50% 13.70 % 11.30 % 14.30% 16.20 % 2.40%
Occupancy in last seven days*
Working as an employee or freelancer 70.7 61.10 % 77.4 0.00 % 0.00% 0.00% 37.90% 50.10 % 57.20 % 60.20% 59.30 % 54.10 %
Working 73.50% 35.40% 46.30 %
Not working but had a job 0.7 0.60% 0.2
Voluntary work 10.20% 2.90% 2.40% 4.80 % 2.10% 3.80%
Looking for work 5.9 9.90% 3.2 8.00 % 11.50 % 11.90 %
Not working, not looking for work 6.7 8.10% 0.3
Unemployed 10.20% 20.60% 14.60 % 17.20% 23.20 % 19.60 %
Studying 7.20 % 3 % 4.30% 6.10 % 4.40% 2.40%
Studying and working 2.70 % 1.10% 5.70% 38.20% 27.90 % 17 % 26.90% 15.50 % 29.30 %
Not working because she is a pensioner, retiree or annuitant 1.00% 0.00 % 0.00% 0.00%
Household activities 5.70 % 9.20% 5 % 2.00 % 0.00% 2.40%
Unable to work 0.50 % 0.60%
Other 0.2 6.40% 2.7 0.00 % 45.60% 31.70 % 15.90% 10.50 % 14 % 5.90 % 11.30 % 10.50 %
Ethnicity*
Afro-Colombian, Afro-descendant, mulatto 8.80 % 6.20% 30.40 % 3.30 % 6 % 15.60 %
Other (Indigenous, Room-Gypsy, Raizal from San Andres, Palenquero from San Basilio) 4 % 6.40% 8.00% 1 % 2.60% 3.60%
None of the above 86.80% 87.30 % 61.60 % 95.70% 91.30 % 80.80 %
Monthly income (colombian money)
No income 16.60% 14.30 % 8.20% 16.30% 19.10% 19.50 % 35 % 24.40 % 14.30 % 16.10% 19.10 % 20.30 %
Between $15,000 and $828,000 47.50% 59.90 % 53.40 % 34.70% 35.30% 46.30 % 24 % 35.20 % 42.30 % 29.00% 25.80 % 28.60 %
Between $828,001 and 1,644,160 20 % 16.00 % 25.60 % 46.90% 39.70% 31.70 % 31.20% 28.90 % 35 % 30.70% 27.80 % 26.30 %
Over $1,644,160 16 % 9.80% 12.80 % 2.00 % 5.90% 2.40% 9.80 % 11.50 % 8.40% 24.20% 27.30 % 24.80 %
Main source of income
Hairdresser, stylist, beautician 19.80% 23.80 % 18.20 %
Dressmaker, designer, seamstress 1.90 % 0.30% 6.10%
Employee 4.60 % 7.30% 12,10 %
Shows 6.80 % 1.50% 13.30 %
Sex work 41,20% 26.30 % 1.10%
Free-lance 4.40 % 17.00 % 9.20%
No income 16.10% 10.20 % 4.60%
Other 5.10 % 13.50 % 35.50 %
Health insurance
Contributive- Subsidised-Special 82.40% 89.20 % 82.80 % 79.60% 83.80% 90.20 % 96.50% 95.00 % 92.60 % 90.90% 87.10 % 85.00 %
Not affiliated 17.60% 10.80 % 17.30 % 20.40% 16.20% 9.80% 3.40 % 5 % 7.40% 9.10 % 13.00 % 15.00 %
Risk behaviors
Number of people with whom you have had penetrative, non commercial intercourse in the last 12 months*
None 6.70 % 1.90% 1.20% 8.20 % 47.10% 14.60 % 12.80% 18.40 % 12.70 %
1 to 4 persons 17.50% 27.00 % 36.30 % 40.80% 22.10% 24.40 % 55 % 47.40 % 58.90 % 62.20% 51.40 % 55.60 %
5 to 10 persons 12.20% 11.20 % 23.70 % 8.20 % 10.30% 14.60 % 32.70% 30.50 % 27.30 % 9.90 % 13.90 % 19.00 %
Over 10 persons 63.60% 59.90 % 38.90 % 42.90% 20.60% 46.30 % 12.30% 22.10 % 13.80 % 15.10% 16.20 % 12.70 %
Have you ever in your life received money in exchange for sex?* (Yes) 87.10% 70.50 % 84.50 % 11.60% 11.10 % 25.90 %
Condom
Do you use condoms?* (Yes) 90.40% 84.20 % 84.00 %
Why have you used condom?*
Comfort 1.30 % 31.70 % 17.80 % 12.50% 52.10 % 12.20 %
Custom 1.20 % 43.20 % 20.10 %
Preventing STIs/HIV 94.30% 97 % 97.10 % 88.30% 95.20 % 85.50 %
To prevent pregnancy 0.40 % 5.90% 5.10% 2.80 % 4 % 2.10%
Hygiene 11.80% 63.40 % 35.60 %
I live with HIV 2 % 15.20 % 4.90%
My partners demand it of me 1.60 % 13 % 4.70%
To care for my partner 8 % 27.60 % 15.10 %
For my care 32.80% 89.50 % 44.10 %
Other 5.70 % 5.20% 7.30% 6.80 % 21.20 % 17.60 %
PrEP knowledge
Have you heard of pre-exposure prophylaxis or PrEP? (Yes) 9.90 % 5.60% 4.80% 14.30% 32.40% 31.70 % 27.10% 39.40 % 15.30 % 55.10% 59.60 % 59.10 %
Have you ever taken pre-exposure therapy? (Yes) 4.10 % 2.70% 1.10% 0.00 % 10.60% 12.20 % 1.70 % 5.70% 4.50 % 12.90% 7.90%
Would you take PrEP to help prevent HIV? (Yes) 39.50% 45.50 % 68.90 % 65.30% 61.80% 61.00 % 63 % 40.20 % 73.10 % 65.30% 61.80 % 61.00 %

* Items asked differently or not requested in the PrEP-Col study: a. How many men (including gay, transgender, transsexual, transvestite, transsexual, transsexual) have you had anal sex within the last six months?

Source: own creation.

Conclusions

PrEP is an acceptable and feasible HIV prevention strategy for reducing HIV incidence in Colombia. PrEP awareness remains low in MSM and TGW in Colombia, yet a large proportion of PrEP-eligible individuals in this group would likely consider taking PrEP. Working on awareness and other early stages of the motivation cascade are needed to ensure that most people eligible for PrEP can initiate and adhere to it. PrEP implementation in Colombia will need a multilevel intervention to address structural factors that would otherwise hinder PrEP adoption and uptake: this includes a multimodal socialization and education campaign, publicly funded PrEP medication and care continuum, and monitoring of relevant outcomes.

Acknowledgments

We thank the participants and organizations of LGBTI for assisting in recruiting survey participants, and special thanks to the PROCREAR and ANCLA foundations.

References

1. ONUSIDA [Internet]. Colombia. Colombia HIV and AIDS Estimates 2022 [cited 2023 Feb]; Available from: Available from: https://www.unaids.org/en/regionscountries/countries/colombiaLinks ]

2. Rick F, Odoke W, van den Hombergh J, Benzaken AS, Avelino-Silva VI. Impact of coronavirus disease (COVID-19) on HIV testing and care provision across four continents. HIV med. 2022;23(2):169-177. [ Links ]

3. Berbesi Fernández DY, Segura Cardona A, Martínez Rocha A, Molina Estrada A,, Ramos Jaraba SM, Bedoya Mejía S, et al. Comportamiento sexual y prevalencia de VIH en hombres que tienen relaciones sexuales con hombres en tres ciudades de Colombia: Bogotá, Medellín y Santiago de Cali, 2019. Medellín, Colombia: Editorial CES; 2019. [ Links ]

4. Berbesi Fernández DY, Segura Cardona AM, Martínez Rocha A, Molina Estrada AP, Martínez A, Ramos Jaraba SM, Bedoya Mejía S, et al. Vulnerabilidad al VIH y prevalencia de VIH en mujeres transgénero en tres ciudades de Colombia: Bogotá, Medellín y Santiago de Cali, 2019. Medellín, Colombia: Editorial CES ; 2019. [ Links ]

5. Montana JF, Ferreira GRON, Cunha CLF, de Queiroz AAR, Fernandes WAA, Polaro SHI, et al. The HIV epidemic in Colombia: spatial and temporal trends analysis. BMC public health. 2021;21(1):178. [ Links ]

6. Frescura L, Godfrey-Faussett P, Feizzadeh AA, El-Sadr W, Syarif O, Ghys PD. Achieving the 95 95 95 targets for all: A pathway to ending AIDS. PLoS One. 2022;17(8):e0272405. [ Links ]

7. Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125. [ Links ]

8. Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O'Reilly KR, Koechlin FM, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973-1983. [ Links ]

9. O Murchu E, Marshall L, Teljeur C, Harrington P, Hayes C, Moran P, et al. Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations. BMJ Open. 2022;12(5):e048478. [ Links ]

10. Traeger MW, Schroeder SE, Wright EJ, Hellard ME, Cornelisse VJ, Doyle JS, et al. Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis. Clin Infect Dis. 2018;67(5):676-686. [ Links ]

11. Jin F, Amin J, Guy R, Vaccher S, Selvey C, Zablotska I, et al. Adherence to daily HIV pre-exposure prophylaxis in a large-scale implementation study in New South Wales, Australia. AIDS. 2021;35(12):1987-1996. [ Links ]

12. Koss CA, Havlir DV, Ayieko J, Kwarisiima D, Kabami J, Chamie G, et al. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda. PLoS medicine. 2021;18(2):e1003492. [ Links ]

13. World Health Organization [Internet]. Global data shows increasing PrEP use and widespread adoption of WHO PrEP recommendations. Available in: https://www.who.int/news-room/feature-stories/detail/global-data-shows-increasing-prep-use-and-widespread-adoption-of-who-prep-recommendationsLinks ]

14. Grulich AE, Jin F, Bavinton BR, Yeung B, Hammoud MA, Amin J, et al. Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study. The lancet HIV. 2021;8(8):e486-e94. [ Links ]

15. Pan American Health Organization and Joint United Nations Programme on HIV/AIDS [Internet]. Washington, D.C.: PAHO, UNAIDS. HIV Prevention in the Spotlight: An Analysis from the Perspective of the Health Sector in Latin America and the Caribbean, 2017.2017. Available in: https://iris.paho.org/handle/10665.2/34381. [ Links ]

16. Luz PM, Veloso VG, Grinsztejn B. The HIV epidemic in Latin America: accomplishments and challenges on treatment and prevention. Curr Opin HIV AIDS. 2019;14(5):366-73. [ Links ]

17. Departamento del Programa Nacional de Prevención y Control del VIH/SIDA e ITS. Orientaciones técnicas 2019 profilaxis pre-exposición (PrEP) a la infección por VIH. Chile. Ministerio de salud; 2019. https://diprece.minsal.cl/wp-content/uploads/2019/08/OT-2019-Profilaxis-Pre-Exposici%C3%B3n-PrEP-a-la-infecci%C3%B3n-por-VIH.pdf (Accessed february, 2022) [ Links ]

18. Luz PM, Benzaken A, Alencar TM, Pimenta C, Veloso VG, Grinsztejn B. PrEP adopted by the brazilian national health system: What is the size of the demand? Medicine (Baltimore). 2018;97(1S Suppl 1):S75-S77. [ Links ]

19. Colombia. Ministerio de Salud y Protección Social. Resolución número 0002292 de 2021. Por la cual se actualizan y establecen los servicios y tecnologías de salud financiados con recursos de la Unidad de Pago por Capitación (UPC). (Dic. 23, 2021) [ Links ]

20. Ministerio de Salud y Protección Social, Empresa Nacional Promotora del Desarrollo Territorial e Instituto de Evaluación Tecnológica en Salud. Guía de Práctica Clínica basada en la evidencia científica para la atención de la infección por VIH/SIDA en personas adultas, gestantes y adolescentes. Versión para profesionales de salud. Bogotá D.C. Colombia; 2021. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ET/gpc-vih-adultos-version-profesionales-salud.pdf (Accessed octuber, 2023) [ Links ]

21. Ministerio de Salud y Protección Social. Dirección de Promoción y Prevención. Profilaxis Preexposición al VIH (PrEP). Lineamiento para la implementación de la PrEP en Colombia. Bogotá D.C. Colombia; 2023. https://prep-colombia.org/wp-content/uploads/2023/07/Lineamiento-PrEP_FINAL_Junio2023.pdf (Accessed octuber,2023) [ Links ]

22. Mueses HF, Alvarado B, Torres J, Camargo P, Bolívar MC, Galindo X, et al. Scales to Assess Knowledge, Motivation, and Self-Efficacy for HIV PrEP in Colombian MSM: PrEP-COL Study. AIDS Res Treat. 2021. [ Links ]

23. Martínez J, Alvarado B, Martínez E, Torres J, Arrivillaga M, Camargo P, et al. HIV care providers' familiarity, concerns, and attitudes about HIV PrEP in Colombia: insights from the PrEP-Col-Study. AIDS Care. 2022;34(11):1428-1434. [ Links ]

24. Bolívar MC, Gomez SA, Camargo P, Peralta MdP, Mueses HF, Alvarado B, et al. Barriers and facilitators to HIV pre-exposure prophylaxis uptake among transgender women in Colombia: A qualitative analysis using the COM-B model. PLOS Glob Public Health. 2023;3(9):e0001395. [ Links ]

25. Parsons JT, Rendina HJ, Lassiter JM, Whitfield THF, Starks TJ, Grov C. Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States: The Motivational PrPEP cascade. J Acquir Immune Defic Syndr. 2017;74(3):285-292. [ Links ]

26. Torres TS, Konda KA, Vega-Ramirez EH, Elorreaga OA, Diaz-Sosa D, Hoagland B, et al. Factors Associated With Willingness to Use Pre-Exposure Prophylaxis in Brazil, Mexico, and Peru: Web-Based Survey Among Men Who Have Sex With Men. JMIR Public Health Surveill. 2019;5(2):e13771. [ Links ]

27. Walsh JL. Applying the Information-Motivation-Behavioral Skills Model to Understand PrEP Intentions and Use Among Men Who Have Sex with Men. AIDS Behav. 2019;23(7):1904-1916. [ Links ]

28. Wilton J, Kain T, Fowler S, Hart TA, Grennan T, Maxwell J, et al. Use of an HIV-risk screening tool to identify optimal candidates for PrEP scale-up among men who have sex with men in Toronto, Canada: disconnect between objective and subjective HIV risk. J Int AIDS Soc. 2016;19(1):20777. [ Links ]

29. Coutinho LM, Scazufca M, Menezes PR. Methods for estimating prevalence ratios in cross-sectional studies. Rev Saúde Publica. 2008;42(6):992-998. [ Links ]

30. Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3(21):1-13. [ Links ]

31. Reisner SL, Moore CS, Asquith A, Pardee DJ, Sarvet A, Mayer G, et al. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States. J Int AIDS Soc. 2019;22(9):e25391. [ Links ]

32. Assaf RD, Konda KA, Torres TS, Vega-Ramirez EH, Elorreaga OA, Diaz-Sosa D, et al. Are men who have sex with men at higher risk for HIV in Latin America more aware of PrEP? PLoS One. 2021;16(8):e0255557. [ Links ]

33. Jalil EM, Grinsztejn B, Velasque L, Ramos Makkeda A, Luz PM, Moreira RI, et al. Awareness, Willingness, and PrEP Eligibility Among Transgender Women in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr. 2018;79(4):445-452. [ Links ]

34. Huang YA, Zhu W, Smith DK, Harris N, Hoover KW. HIV Preexposure Prophylaxis, by Race and Ethnicity - United States, 2014-2016. MMWR Morb Mortal Wkly Rep. 2018;67(41):1147-1150. [ Links ]

35. Yi S, Tuot S, Mwai GW, Ngin C, Chhim K, Pal K, et al. Awareness and willingness to use HIV preexposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis. J Int AIDS Soc. 2017;20(1):21580. [ Links ]

36. Powers KA, Miller WC. Critical Review: Building on the HIV Cascade: A Complementary "HIV States and Transitions" Framework for Describing HIV Diagnosis, Care, and Treatment at the Population Level. J Acquir Immune Defic Syndr. 2015;69(3):341-347. [ Links ]

37. Seckinelgin H. People don't live on the care cascade: The life of the HIV care cascade as an international AIDS policy and its implications. Glob Public Health. 2020;15(3):321-333. [ Links ]

38. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399-410. [ Links ]

39. Mueses-Marín HF, Alvarado-Llano BE, Tello-Bolívar IC, Martínez-Cajas JL, Galindo-Quintero J. Examining a syndemic framework for HIV and sexually transmitted infections risk in Cali, Colombia. Hacia Promoc. Salud. 2020;25(2):140-153. [ Links ]

40. Edeza A, Galarraga O, Novak D, Mayer K, Rosenberger J, Mimiaga M, et al. The role of sexual risk behaviors on PrEP awareness and interest among men who have sex with men in Latin America. Int J STD AIDS. 2019;30(6):542-549. [ Links ]

41. Torres TS, Luz PM, De Boni RB, de Vasconcellos MTL, Hoagland B, Garner A, et al. Factors associated with PrEP awareness according to age and willingness to use HIV prevention technologies: the 2017 online survey among MSM in Brazil. AIDS Care. 2019;31(10):1193-1202. [ Links ]

42. Mosley T, Khaketla M, Armstrong HL, Cui Z, Sereda P, Lachowsky NJ, et al. Trends in Awareness and Use of HIV PrEP Among Gay, Bisexual, and Other Men who have Sex with Men in Vancouver, Canada 2012-2016. AIDS Behav. 2018;22(11):3550-3565. [ Links ]

43. McMahan VM, Moreno C, Al-Tayyib A, Menza TW, Orellana ER, Bhattarai A, et al. Pre-exposure Prophylaxis Awareness and Use Among Cisgender Men Who Have Sex With Men and Use Methamphetamine in 3 Western US Cities. Sex Transm Dis. 2020;47(4):217-223. [ Links ]

44. Pacífico de Carvalho N, Mendicino CCP, Cândido RCF, Alecrim DJD, Menezes de Pádua CA. HIV pre-exposure prophylaxis (PrEP) awareness and acceptability among trans women: a review. AIDS Care. 2019;31(10):1234-1240. [ Links ]

45. Sevelius JM, Poteat T, Luhur WE, Reisner SL, Meyer IH. HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States. J Acquir Immune Defic Syndr. 2020;84(5):437-442. [ Links ]

46. Zea MC, Reisen CA, del Río-González AM, Bianchi FT, Ramirez-Valles J, Poppen PJ. HIV Prevalence and Awareness of Positive Seorstatus Among Men Who Have Sex Whit Men and Transgender Women in Bogotá, Colombia. Am J Public Health. 2015;105(8):1588-1595. [ Links ]

47. Galea JT, Kinsler JJ, Salazar X, Lee SJ, Giron M, Sayles JN, et al. Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. Int J STD AIDS. 2011;22(5):256-262. [ Links ]

48. Hoagland B, De Boni RB, Moreira RI, Madruga JV, Kallas EG, Goulart SP, et al. Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil. AIDS Behavior. 2017;21(5):1278-1287. [ Links ]

49. Camila-Bolívar M, Gomez-Peñaloza SA, Camargo-Plazas P, Peralta-Ardila MDP, Mueses-Marín HF, Alvarado-Llano B, et al. Barriers and facilitators to HIV pre-exposure prophylaxis uptake among transgender women in Colombia: A qualitative analysis using the COM-B model. PLOS Global Public Health. 2023;3(9): e0001395. [ Links ]

50. Corporación de lucha contra el sida [Internet]. Colombia: Corporación de lucha contra el sida; 1992-2024. Estudio PREP COL; [Citado 2024, mayo 19]; Disponible en: Disponible en: https://cls.org.co/proyecto-prep/Links ]

51. Keen P, Bavinton BR. Could disparities in PrEP uptake limit the public health benefit?. Lancet Public Health. 2020;5(9):e467-e468. [ Links ]

52. Holt M, Lee E, Lea T, Bavinton B, Broady T, Mao L, et al. HIV Preexposure Prophylaxis Cascades to Assess Implementation in Australia: Results From Repeated, National Behavioral Surveillance of Gay and Bisexual Men, 2014-2018. J Acquiur Immune Defic Syndr. 2020;83(3):e16-e22. [ Links ]

53. Hanum N, Cambiano V, Sewell J, Phillips AN, Rodger AJ, Speakman A, et al. Use of HIV preexposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study. Lancet Public Health. 2020;5(9):e501-e511. [ Links ]

54. Annequin M, Villes V, Delabre RM, Alain T, Morel S, Michels D, et al. Are PrEP services in France reaching all those exposed to HIV who want to take PrEP? MSM respondents who are eligible but not using PrEP (EMIS 2017). AIDS Care. 2020;32(sup2):47-56. [ Links ]

55. Morgan J, Ferlatte O, Salway T, Wilton J, Hull M. Awareness of, interest in, and willingness to pay for HIV pre-exposure prophylaxis among Canadian gay, bisexual, and other men who have sex with men. Can J Public Health. 2018;109(5-6):791-799. [ Links ]

¿Cómo citar este artículo? Mueses-Marín HF, Alvarado-Llano BE, Bolivar-Rocha MC, Galindo-Orrego X, Torres-Isasiga JA, Martínez-Cajas JL. HIV Pre-exposure Prophylaxis Awareness, Eligibility and Intention in Men Who Have Sex with Men and Transgender Women: a cross-sectional study in Colombia 2020 -2021. MÉD.UIS. 2024;37(2): 77-99. DOI: https://doi.org/10.18273/revmed.v37n2-2024007

Data Availability The "data" used to support the findings of this study may be requested upon application to the corresponding author.

Funding This work was supported by grants from the Ministry of Science-Colombia-(Code:334780762872).

Supplementary material

Supplementary Table 1. Comparative studies of awareness, willingness, and intention to take PrEP in Latin American countries.

Supplementary Table 2. Comparative table with sample of MSM and TGW recruited by Berbesy et al

Received: October 10, 2023; Accepted: April 28, 2024

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License